Clinical Trial Update: Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting

View source ↗

Summary

A completed clinical trial evaluated circulating tumor DNA (ctDNA) analysis as a tool for earlier detection of melanoma recurrence in high-risk patients. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Melanoma

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Stage III Melanoma, Stage IV Cutaneous Melanoma | Status: COMPLETED